Vastmindz logo

See Vastmindz’s episode in the new TV show, UNICORN HUNTERS

Vastmindz AI (Artificial Intelligence) is a technology company that provides a SaaS (“Software As A Service”)  that can remotely determine physiological insights remotely.

Copy of VM Cover

Global Private Placement ($10,000 minimum investment)

01/10/2022

Launch Date

05/31/2022

Close Date

$6.60

Share Price

$60,000,000

Valuation

Updates:

Vastmindz Investment Holdings LLC, a newly formed Delaware limited liability company organized by Vastmindz AI Ltd a company based in United Kingdom. (“Vastmindz”) is offering limited liability company interests to eligible investors.

Vastmindz Investment Holdings LLC will invest the proceeds from the offering in ordinary shares of Vastmindz.  Vastmindz is offering Vastmindz Investment Holdings LLC the opportunity to purchase up to 1,500,000 ordinary shares at a purchase price of $6.60 per share based on a $60,000,000 valuation.

(Terms subject to change.  This investment involves significant risks, as described in the offering materials. Read all offering materials carefully as they contain important information regarding this offering.)

 
For More Information Email: [email protected]

About Vastmindz

divider

At Vastmindz, we aim to transform standard consumer technology devices into a comprehensive non-invasive health & wellness tool using artificial intelligence and signal processing. Our technology, has the opportunity to positively impact lives, by empowering them to better understand their health state.

With the rise of health care costs, there’s never been a more important time to be proactive about managing your health. Our technology allows industries like Insurance companies and telemedicine providers to integrate into their applications to help lower the cost of healthcare but also puts you in control of managing your own health.

Solution

The problem we solve

divider

Remotely monitoring physiological signs is an integral component to improving health & wellness, however there is no easy way to do this. Until now. The global telemedicine market has seen a massive increase in demand and expected to be a $390 billion market by 2027. 

By analyzing a video feed of an individual’s face, we are able to extract various physiological parameters in less than 60 seconds remotely. Allowing telemedicine providers to add significant features to their offerings. Our AI based health monitoring system uses proprietary technology and works on any device with an embedded camera, delivering a powerful solution for remote monitoring of vital signs.

Our Solution

divider

We enhance camera sensors to remotely measure physiological signs using proprietary AI. Our solution is able to remotely extract this data from a face using signal processing and AI. 

Our solution captures health & wellness data in the most accessible way, allowing organisations to understand trends. These trends can be used to form health trajectories and provide insights as to when to take preventative action.

Please note that we are not a replacement for a medical advisor or health care professional.
Vastmindz Solutiom
Financial projections

Financial projections

divider

We already have customers who are using our services and our projections for the next five years shows how we expect be a high-growth SaaS business with Annual recurring revenues (ARR) of ~$160M by FY25. 

Our first few years represents cautious growth whilst we await regulatory approval. Once we achieve this approval, we expect the rate of customer acquisition and the use cases for different markets will increase significantly with rapid adoption in different industries globally.

Market Opportunity

divider

The market opportunity for our solution crosses many industries including telemedicine, which is projected to be a $390 billion market by 2027,  health/life insurance which is projected to be $3 trillion by 2028 and other related health & wellness industries. The animal health & wellness industry is currently $46 billion and expected to grow rapidly over the next 10 years. According to McKinsey, the global wellness market is currently estimated at $1.5 trillon and is expected to experience annual growth in high single-digit % (read more).

Our initial focus is to address key industries that can immediately benefit from capturing physiological signs from their users remotely. Our use cases are increasing over time and with the introduction of our animal health solution, this will expand our total addressable market even further.

Market opportunity

The world’s first contactless monitoring solution for pets

divider
biopawz

Signed customers

divider

In the Press

divider
South Korea's presidential Deepfake

South Korea’s presidential Deepfake

Introduction/Background The president-elect of South Korea, Yoon Suk-yeol, used an unusual strategy during his campaign earlier this year. His campaign team used Deepfakes to make

The Team

divider
Nikhil Sehgal

Nikhil Sehgal

Founder & Chief Executive Officer

Nikhil founded Vastmindz following an algorithmic trading background in some leading global Banks, and then decided to apply innovative data science methodologies to the field of healthcare. He is the CEO and currently leads the research science team at Vastmindz, utilising the latest methods in computer vision and biomedical signal processing to build Vastmindz’s product portfolio.

Sundeep Bhandari

Sundeep Bhandari

Chief Strategy Advisor

Sundeep is an independent NED for one of India’s largest banks and is a trustee with the charity, 15 billion-EBP. He has previously held several senior positions within Standard Chartered Bank and Barclays, working both domestically in the UK as well as internationally. Sundeep actively engages as a mentor with Virgin start-ups, supporting young and ambitious entrepreneurs.
Stephen Mackinnon

Prof. Stephen Mackinnon

Chief Medical Officer
Stephen is one of London’s leading haematologists. He leads the bone marrow and stem cell program at UCL and specialises in leukaemia, lymphoma, myeloma and stem cell transportation. The results of his research have led to world-class patient outcomes and he has been widely recognised in many peer-reviewed journals.
Raj Sharma

Raj Sharma

Chief Technology Officer

Raj has over 10+ years of experience with working with cutting-edge technology across robotics, artificial intelligence & cybersecurity and is responsible for ensuring that Vastmindz’s technology stack is scalable and secure. Raj also is a guest speaker at the University of Oxford and has authored courses on artificial intelligence for the institution.

Pavlo Vyplavin

Pavlo Vyplavin, PhD

Chief Research Scientist

Following a PhD in Radiophysics, Pavlo has spent over 15 years working as a scientific researcher, working with noise radars, signal processing, SAR imaging, SAR interferometry, phased array antennas and pulsed doppler radars. He now works to develop innovative biomedical solutions for Vastmindz’s product portfolio.

Melvin D Lobo

Professor Melvin D Lobo

Chief Clinical Advisor

MBChB PhD FRCP FBHS FESC FACC.
Professor Melvin Lobo is a Consultant Cardiovascular Physician and Director of the Bart’s Blood Pressure Clinic and the William Harvey Research Institute. He has a specialist interest in blood pressure disorders of all types, PoTS and autonomic control of the circulation. He is an accredited Clinical Hypertension Specialist of the European Society of Hypertension (ESH) and British Hypertension Society.
Ellipse 107 5

Luis Felipe De Deus

Research Scientist

Luis is an expert in biomedical engineering and has developed several innovative methodologies in the field of non-invasive biometric monitoring. Luis also leads research efforts at Vastmindz with external academic collaborators.

Carol Cunningham

Miss Carol Cunnigham

Scientific Board Advisor
Miss Cunningham recently retired from Moorfields Eye Hospital and private practice as a Consultant Ophthalmic Surgeon after 24 years. She performed several types of highly specialised eye-surgery. She graduated from Columbia University and New York University Medical School and participated and published in neuroanatomy research at Columbia Presbyterian Hospital.
Kostya Shpachenko

Kostya Shpachenko

Software Architect Lead
Kostya has several years of experience with building highly scalable infrastructure to optimise the operation of computationally intense solutions. Kostya leads Vastmindz’s DevOps team, operating and scaling Vastmindz’s cloud infrastructure to serve clients as seamlessly as possible.

Use of Proceeds

If the offering’s maximum allocation of $10,000,000 is raised, we aim to use the proceeds to help the business grow dramatically. 

We already have a product, we already have customers and we are seeking to invest in key areas like regulatory approvals (which are in progress) and to invest in building out our sales initiatives. We continue to invest in R&D and seeking to additionally resource our development teams so that we can get innovative solutions to market with velocity. All of our infrastructure is based in the cloud and as we scale and take on more customers, our cloud spend will increase and hence an additional element of funding will be used for that purpose.

Use of Proceeds

Key Terms

Vastmindz AI Ltd, a limited company organized under the laws of England and Wales (“the Portfolio Company”) has sponsored the formation of a newly formed Delaware limited liability company Vastmindz Investments Holdings LLC (‘the Fund”).

The Fund has been formed for the sole purpose of purchasing unregistered ordinary shares of Vastmindz (“Portfolio Company Securities”). The Portfolio Company Securities will be acquired by the Fund directly in a private placement conducted by Vastmindz in accordance with Regulation D of the Securities Act of 1933 (the “Private Placement”) .

The Fund is offering, through its private placement memorandum, its limited liability company interests (the “Interests”) on a private placement basis to investors who satisfy the eligibility standards described in this private placement memorandum. Persons whose subscriptions are accepted by the Fund will be admitted as members of the Fund (“Members”). Each Interest includes the right of that Member to all benefits to which a Member may be entitled pursuant to the Operating Agreement and under applicable law, together with all obligations of the Member to comply with the terms and provisions of the Operating Agreement and applicable law.

(Terms subject to change. This investment involves significant risks, as described in the offering materials. Read all offering materials carefully as they contain important information regarding this offering.)

Important Disclosures

Any information in this Website and other financial information has been prepared for informational purposes only and does not purport to contain all the information that a prospective purchaser may require in evaluating and making a purchase decision.

In every case, interested parties should perform their own due diligence on Vastmindz Investment Holdings LLC and its affiliate Vastmindz AI Ltd (collectively known as “Vastmindz”) and all opportunities presented here for investment.

Vastmindz and its affiliates, officers, employees, representatives or advisors do not make any representations or warranties, explicit or otherwise, as to the accuracy or completeness of the information herein or otherwise made available in connection with any further investigation of Vastmindz, , including but limited to any financial projections, forecasts or budgets (collectively the “Projections”), and Vastmindz expressly disclaims any and all liability that may be based on or arise from such information, errors therein or omissions therefrom.

Nothing herein or otherwise made available shall be construed as giving legal, financial, tax or other advice of any kind.  Availability of this Website shall not and does not, under any circumstance, create any implication or inference that the information contained herein is correct or complete.

Certain information contained in this Website and the Projections constitutes “forward-looking statements,” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995.  Many of the forward-looking statements contained in this Website or the Projections can be identified using forward-looking terminology such as “may,” “will,” “should,” “forecast”, “expect,” “anticipate,” “project,” “estimate,” “intend,” “continue,” “target,” or “believe,” or the negatives thereof or other variations thereon or comparable terminology, among others. Due to various risks and uncertainties, actual events or results or the actual performance of Vastmindz as described in this Website or the Projections may differ materially from those reflected or contemplated in such forward-looking statements.  These risks and uncertainties include but are not limited to factors relating to changes in the estimated financial performance of Vastmindz, changes in customer relationships of Vastmindz, changes in the regulatory process, changes in the management team of Vastmindz, potential ongoing effects of the current novel Coronavirus-19 pandemic and changes in the macro economy.  Forward-looking statements are only current expectations and are based on Vastmindz assumptions and on information currently available to Vastmindz.  Any such forward-looking statements speak only as of their dates, and no obligation is undertaken to update any such statements, whether because of new information, further events or otherwise. In addition, interested parties should bear in mind the effects of transaction costs and other expenses to be borne by such interested parties, which in the aggregate may be substantial.

Vastmindz shall have no legal commitment or obligation to any interested party reviewing this Website or the Projections unless a binding written agreement has been fully executed between the parties, delivered and approved by Vastmindz.

Our solutions are not a replacement for a healthcare professional and our solution does not diagnose, prevent, provide any treatment for any form of illness or disease.

AI-powered insights for health & wellness

Copyright 2021 Vastmindz AI Ltd All Rights Reserved.

Investor Relations

Email: [email protected]